TY  - GEN
AU  - Danese,S
AU  - Angelucci,E
TI  - New and emerging biologics in the treatment of inflammatory bowel disease: quo vadis?
SN  - 0399-8320
PY  - 2010///1217
KW  - Anti-Inflammatory Agents
KW  - pharmacology
KW  - Antibodies, Monoclonal
KW  - Biological Products
KW  - therapeutic use
KW  - Clinical Trials as Topic
KW  - Colitis, Ulcerative
KW  - therapy
KW  - Crohn Disease
KW  - Drug Therapy, Combination
KW  - Humans
KW  - Inflammatory Bowel Diseases
KW  - drug therapy
KW  - Randomized Controlled Trials as Topic
KW  - Treatment Outcome
KW  - Tumor Necrosis Factor-alpha
KW  - antagonists & inhibitors
N1  - Publication Type: Journal Article; Review
UR  - https://doi.org/10.1016/S0399-8320(09)73157-4
ER  -